|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | ||||||||||||
| Grants receivable | ||||||||||||
| Accounts Receivable | ||||||||||||
| Prepaid expenses | ||||||||||||
| Total Current Assets | ||||||||||||
| Furniture, fixtures and equipment | ||||||||||||
| Furniture, fixtures and equipment (Accumulated Depreciation) | ||||||||||||
| Furniture and fixtures, net | ||||||||||||
| Operating lease right of use asset | ||||||||||||
| Total Assets | ||||||||||||
| Accounts payable | ||||||||||||
| Accrued expenses | ||||||||||||
| Operating lease liability | ||||||||||||
| Payroll liability | ||||||||||||
| Notes payable, current | ||||||||||||
| Related party loan | ||||||||||||
| Related party interest | ||||||||||||
| Total Current Liabilities | ||||||||||||
| Operating lease liability, net of current portion | ||||||||||||
| Total Liabilities | ||||||||||||
| Preferred stock, value | ||||||||||||
| Series B Preferred Stock | ||||||||||||
| Series C Preferred Stock | ||||||||||||
| Total preferred stock, value | ||||||||||||
| Common stock, $0.0001 par value per share, 200,000,000 shares authorized, 4,620,837 shares issued and outstanding at September 30, 2025 and 1,208,919 shares issued and outstanding at December 31, 2024 | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Accumulated deficit | ||||||||||||
| Total stockholders’ equity | ||||||||||||
| Total liabilities and stockholders’ equity |
Loading...
